SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

29 hedge funds and large institutions have $522M invested in Sinovac Biotech, Ltd in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$781K
2
+$55.4K
3
+$19K
4
Morgan Stanley
Morgan Stanley
New York
+$6.4K

Top Sellers

1
-$34.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$405M
2
$72M
3
$38.2M
4
$2.04M
5
$1.82M
6
$1.54M
7
$485K
8
$259K
9
$179K
10
$117K
11
$106K
12
$55K
13
$27K
14
$19K
15
$16K
16
$1K
17
$798